Calidi Biotherapeutics, Inc.
CLDWW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCLDI
Q4 2024 vs. Q3 2024
How the institutions holding Calidi Biotherapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 16 | 1 | −15 |
| Shares | 5.89M | 105.0K | −5.78M (−98.2%) |
| Value | $99.4K | $1.01K | −$98.4K (−99.0%) |
New holders (0)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
None.
Sold out (15)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Polar Asset Management Partners Inc. | 2,165,086 | $30.2K |
| Highbridge Capital Management LLC | – | $20.7K |
| Driehaus Capital Management LLC | 750,000 | $9.30K |
| Finepoint Capital LP | 655,200 | $8.58K |
| 683 Capital Management, LLC | 599,702 | $7.86K |
| Aristeia Capital LLC | 494,400 | $6.90K |
| Nomura Holdings Inc | 467,818 | $6.08K |
| Shaolin Capital Management LLC | 330,547 | $4.33K |
| Cowen and Company, LLC | 171,536 | $2.25K |
| Citadel Advisors LLC | 70,701 | $926 |
| Walleye Capital LLC | 36,469 | $478 |
| Walleye Trading LLC | 20,052 | $263 |
| Clear Street LLC | 6,617 | $87 |
| UBS Group AG | 5,398 | $70 |
| Flow Traders U.S. LLC | 11,427 | $0 |